J. Am. Chem. Soc., 1982, 104, 6697; (c) L. Eberson, M. Malmberg
and K. Nyberg, Acta Chem. Scand., Ser. B, 1984, 38, 391;
(d) M. Chigr, H. Fillion and A. Rougny, Tetrahedron Lett.,
1987, 28, 4529; (e) P. Wipf and X. Wang, Tetrahedron Lett.,
2000, 41, 8747.
2 For the reports on the use of enamides and enecarbamates as
nucleophiles, see: (a) R. Matsubara and S. Kobayashi, Acc. Chem.
Res., 2008, 41, 292; (b) R. Matsubara and S. Kobayashi, Angew.
Chem., Int. Ed., 2006, 45, 7993; (c) F. Berthiol, R. Matsubara,
N. Kawai and S. Kobayashi, Angew. Chem., Int. Ed., 2007, 46,
7803; (d) R. Matsubara, T. Doko, R. Uetake and S. Kobayashi,
Angew. Chem., Int. Ed., 2007, 46, 3047; (e) L. Zu, H. Xie, H. Li,
J. Wang, X. Yu and W. Wang, Chem.–Eur. J., 2008, 14, 6333;
(f) Y. Hayashi, H. Gotoh, R. Masui and H. Ishikawa, Angew.
Chem., Int. Ed., 2008, 47, 4012; (g) H. Liu, G. Dagousset,
G. Masson, P. Retailleau and J. P. Zhu, J. Am. Chem. Soc.,
2009, 131, 4598.
Scheme 1 Substrate scope for the aza-ene-type reaction.
3 For a general review of the ene reaction, see: (a) K. Mikami and
M. Shimizu, Chem. Rev., 1992, 92, 1021; (b) D. J. Berrisford and
C. Bolm, Angew. Chem., Int. Ed. Engl., 1995, 34, 1717;
(c) K. Mikami, M. Terada, S. Narisawa and T. Nakai, Synlett,
1992, 255; (d) K. Mikami, Pure Appl. Chem., 1996, 68, 639;
(e) K. C. Nicolaou, D. W. Kim and R. Baati, Angew. Chem., Int.
Ed., 2002, 41, 3701; (f) K. R. Hornberger, C. L. Hamblett and
J. L. Leighton, J. Am. Chem. Soc., 2000, 122, 12894; (g) Y. Yuan,
X. Zhang and K. Ding, Angew. Chem., Int. Ed., 2003, 42, 5478;
(h) J. F. Zhao, H. Y. Tsui, P. J. Wu, J. Lu and T. P. Loh, J. Am.
Chem. Soc., 2008, 130, 16492, and references therein.
4 (a) R. Matsubara, Y. Nakamura and S. Kobayashi, Angew. Chem.,
Int. Ed., 2004, 43, 1679; (b) R. Matsubara, Y. Nakamura and
S. Kobayashi, Angew. Chem., Int. Ed., 2004, 43, 3258;
(c) R. Matsubara, P. Vital, Y. Nakamura, H. Kiyohara and
S. Kobayashi, Tetrahedron, 2004, 60, 9769; (d) J. S. Fossey,
R. Matsubara, P. Vital and S. Kobayashi, Org. Biomol. Chem.,
2005, 3, 2910; (e) R. Matsubara, N. Kawai and S. Kobayashi,
Angew. Chem., Int. Ed., 2006, 45, 3814; (f) H. Kiyohara,
R. Matsubara and S. Kobayashi, Org. Lett., 2006, 8, 5333.
5 (a) M. Terada, K. Machioka and K. Sorimachi, Angew. Chem., Int.
Ed., 2006, 45, 2254; (b) M. Terada, K. Machioka and
K. Sorimachi, J. Am. Chem. Soc., 2007, 129, 10336;
(c) M. Terada, K. Soga and N. Momiyama, Angew. Chem., Int.
Ed., 2008, 47, 4122.
Fig. 2 Proposed transition-state and the X-ray crystallographic
structure of the (S)-product 5l.
configuration of product,9,10 a concerted transition-state model
was proposed.11 As shown in Fig. 2, the glyoxal derivative
tended to coordinate to the nickel(II) in a bidentate fashion.4b
The Re face of the glyoxal derivative was shielded by the
neighboring 2,6-diisopropylphenyl group of the ligand, and
the nucleophile (enamide or enecarbamate) attacked from the
Si face predominantly to give the S-configured product.
In conclusion, we have developed an efficient chiral N,N0-
dioxide-nickel(II) complex catalyst for the enantioselective
aza-ene-type reaction of glyoxal derivatives as well as
glyoxylate. The extremely high enantioselectivity, broad
substrate scope, operational simplicity, and mild reaction
conditions demonstrated that the N,N0-dioxide-nickel(II)
complex was excellent catalyst for the synthesis of optical
2-hydroxy-1,4-dicarbonyl compounds. Further studies of the
reaction mechanism and application of this catalyst to other
reactions are under way.
6 K. Zheng, J. Shi, X. H. Liu and X. M. Feng, J. Am. Chem. Soc.,
2008, 130, 15770.
7 For reviews on chiral N-oxides in asymmetric catalysis, see:
(a) G. Chelucci, G. Murineddu and G. A. Pinna, Tetrahedron:
Asymmetry, 2004, 15, 1373; (b) A. V. Malkov and P. Kocovsky
´ ,
Eur. J. Org. Chem., 2007, 29, and references therein.
8 For other examples of metal-N,N0-dioxide complex, see:
(a) Z. P. Yu, X. H. Liu, Z. H. Dong, M. S. Xie and X. M. Feng,
Angew. Chem., Int. Ed., 2008, 47, 1308; (b) X. Yang, X. Zhou,
L. L. Lin, L. Chang, X. H. Liu and X. M. Feng, Angew. Chem., Int.
Ed., 2008, 47, 7079; and references therein.
We appreciate the National Natural Science Foundation of
China (Nos. 20732003 and 20872096) and PCSIRT (No.
IRT0846) and National Basic Research Program of China
(973 Program) (No. 2010CB833300) for financial support. We
also thank Sichuan University Analytical & Testing Center for
NMR and X-ray analysis and the State Key Laboratory of
Biotherapy for HRMS analysis.
9 More data see Supporting Informationw.
10 CCDC-750144 and CCDC-739905 contains the supplementary
crystallographic data for this paper. These data can be obtained
free of charge from The Cambridge Crystallographic Data Centre
References
11 (a) S. Bahmanyar and K. N. Houk, J. Am. Chem. Soc., 2001, 123,
11273; (b) D. A. Evans, S. Mito and D. Seidel, J. Am. Chem. Soc.,
2007, 129, 11583; (c) K. Itoh, M. Hasegawa, J. Tanaka and
S. Kanemasa, Org. Lett., 2005, 7, 979, and references therein.
1 (a) P. J. Jessup, C. B. Petty, J. Roos and L. E. Overman,
Org. Synth., 1980, 59, 1; (b) T. Shono, Y. Matsumura,
K. Tsubata, Y. Sugihara, S. Yamane, T. Kanazawa and T. Aoki,
ꢀc
This journal is The Royal Society of Chemistry 2010
Chem. Commun., 2010, 46, 3771–3773 | 3773